Eric Devroe
2021
In 2021, Eric Devroe earned a total compensation of $462.9K as Chief Operating Officer at Acrivon Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $75,000 |
|---|---|
| Option Awards | $87,939 |
| Salary | $300,000 |
| Total | $462,939 |
Devroe received $300K in salary, accounting for 65% of the total pay in 2021.
Devroe also received $75K in non-equity incentive plan and $87.9K in option awards.
Rankings
In 2021, Eric Devroe's compensation ranked 10,881st out of 12,415 executives tracked by ExecPay. In other words, Devroe earned more than 12.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,881 out of 12,415 | 12th |
Division Manufacturing | 4,794 out of 5,508 | 13th |
Major group Chemicals And Allied Products | 2,148 out of 2,378 | 10th |
Industry group Drugs | 1,910 out of 2,099 | 9th |
Industry Pharmaceutical Preparations | 1,414 out of 1,549 | 9th |
Source: SEC filing on May 1, 2023.
Devroe's colleagues
We found one more compensation record of an executive who worked with Eric Devroe at Acrivon Therapeutics in 2021.
2021
Peter Blume-Jensen
Acrivon Therapeutics